Vireo Growth (VREOF) Revenue (2020 - 2026)
Vireo Growth (VREOF) posted Revenue of $106.2 million for Q1 2026, up 1.62% sequentially from $104.5 million in Q4 2025, and up 333.47% YoY from $24.5 million in Q1 2025.
Vireo Growth (VREOF) Revenue (2020 - 2026) Analysis & Trends
Vireo Growth has reported Revenue for 7 years, with the latest figure at $106.2 million in Q1 2026.
- Quarterly Revenue rose 333.47% year-over-year to $106.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $350.4 million (up 251.14% YoY) and the FY2025 annual result came in at $268.8 million, up 170.43% from the prior year.
- Revenue grew to $106.2 million in Q1 2026 per VREOF's latest filing, from $104.5 million in the prior quarter.
- Over five years, Revenue peaked at $106.2 million in Q1 2026 and troughed at $15.6 million in Q1 2022.
- A 5-year average of $37.5 million and a median of $24.5 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2026: Revenue declined 4.24% in 2023, then soared 333.47% in 2026.
- Over 5 years, Revenue stood at $19.0 million in 2022, then increased by 26.94% to $24.2 million in 2023, then gained by 3.52% to $25.0 million in 2024, then soared by 317.65% to $104.5 million in 2025, then increased by 1.62% to $106.2 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $106.2 million, $104.5 million, and $91.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 106.20 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 1.37 Bn |
| 10 | HUTCHMED (China) | 10.92 Bn | 9.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.20 Mn |
| Dec 31, 2025 | 104.51 Mn |
| Sep 30, 2025 | 91.66 Mn |
| Jun 30, 2025 | 48.06 Mn |
| Mar 31, 2025 | 24.50 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 25.17 Mn |
| Jun 30, 2024 | 25.11 Mn |
| Mar 31, 2024 | 24.09 Mn |
| Dec 31, 2023 | 24.17 Mn |
| Sep 30, 2023 | 24.68 Mn |
| Jun 30, 2023 | 20.20 Mn |
| Mar 31, 2023 | 19.09 Mn |
| Dec 31, 2022 | 19.04 Mn |
| Sep 30, 2022 | 18.85 Mn |
| Jun 30, 2022 | 21.09 Mn |
| Mar 31, 2022 | 15.64 Mn |
| Dec 31, 2021 | 13.66 Mn |
| Sep 30, 2021 | 13.37 Mn |
| Jun 30, 2021 | 14.23 Mn |